Pluma - GLP1 Tracker
Scaleway Digital LLC Health & Fitness iPhoneiPadiPod touch
Pluma - GLP1 Tracker is a free Health & Fitness app for iPhone and iPad by Scaleway Digital LLC. Requires iOS 15.1. Updated July 22, 2026.
- Price
- Free
- on the App Store
- Size
- 55 MB
- Age 17+
- Updated
- Jul 22
- 2026 · v1.0.2
Screenshots
About Pluma - GLP1 Tracker
Pluma helps you stay consistent, informed, and in control throughout your GLP-1 journey. Whether you're tracking semaglutide, tirzepatide, or another GLP-1 medication, Pluma gives you a simple way to log your doses, monitor your progress, and better understand your routine over time. With a clean, intuitive experience, Pluma helps you stay organized and motivated—so you can focus on feeling your best. With Pluma, you can: • Log your doses and keep a clear record of your medication schedule • Track your weight and visualize your progress over time • See medication levels in your body with easy-to-understand charts • Log shot sites and rotate injection areas with confidence • Build streaks to stay consistent with your routine • Join the community and connect with others on a similar journey • Review your history and keep all your progress in one place Pluma is designed to make GLP-1 tracking feel simple, supportive, and motivating. Stay consistent. Stay informed. Keep moving forward. Pluma is a tracking and educational support app. It does not provide medical advice, diagnosis, or treatment. Always follow your healthcare provider's guidance before starting, stopping, or changing any medication, dose, diet, or exercise routine. Pluma is not affiliated with, endorsed by, or sponsored by any pharmaceutical manufacturer. Medication names are trademarks of their respective owners and are used only so you can track your treatment. Pluma Pro Subscription Access to the features above—GLP-1 journey tracking, dose logging, weight progress, medication level charts, community, and history—requires a Pluma Pro subscription. A free trial is available before you're charged. • Payment will be charged to your Apple ID account at confirmation of purchase. • Subscription automatically renews unless auto-renew is turned off at least 24 hours before the end of the current period. • Your account will be charged for renewal within 24 hours prior to the end of the current period. • You can manage or cancel your subscription anytime in your App Store account settings. • Any unused portion of a free trial will be forfeited when you purchase a subscription. Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
What’s new
Version 1.0.2 · Updated July 22, 2026
Bug fixes.
App privacy
The developer, Scaleway Digital LLC, reported these privacy practices to Apple.
Data Linked to You
The following data, which may be collected and linked to your identity, may be used for the following purposes:
- Health & Fitness: Health
- Contact Info: Email Address, Name
- User Content: Photos or Videos
- Identifiers: User ID
Used for: App Functionality
Data Not Linked to You
The following data, which may be collected but is not linked to your identity, may be used for the following purposes:
- Location: Coarse Location
Used for: App Functionality
Alternatives to Pluma - GLP1 Tracker
Looking for apps like Pluma - GLP1 Tracker? Here are 6 similar apps on the App Store. The highest rated is Lumara: GLP-1, Peptide Tracker (5.0/5), and all 6 are free to download.
-
Preserve: GLP-1 Muscle Tracker
-
Luma: GLP-1 Tracker
-
NuMacros
-
Titrate - GLP-1 Dose Tracker
-
GLP 1 Tracker: Pepy's
-
Lumara: GLP-1, Peptide Tracker
5.0
| App | Rating | Price | Last updated | Compare |
|---|---|---|---|---|
| Pluma - GLP1 Tracker | – | Free | July 22, 2026 | |
| Preserve: GLP-1 Muscle Tracker | – | Free | Aug 21, 2026 | Compare |
| Luma: GLP-1 Tracker | – | Free | May 20, 2026 | Compare |
| NuMacros | – | Free | Nov 12, 2025 | Compare |
| Titrate - GLP-1 Dose Tracker | – | Free | Mar 25, 2026 | Compare |
| GLP 1 Tracker: Pepy's | – | Free | Aug 19, 2026 | Compare |
| Lumara: GLP-1, Peptide Tracker | 5.0 / 5 (1) | Free | Oct 15, 2026 | Compare |